Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing–remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis

QR Code

Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing–remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Christopher Oldmeadow, Angela Smith, Madeleine Hinwood, Danielle Lang, Samuel Lees, Mathew Dicker, Jie En Ku, Varun Chaganti, Matthew Mew-Sum, Nick Wang, Wooi Lynn Goon, Marc Bevan
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Medicine R
Accès en ligne:	https://doaj.org/article/5ae081a7c0384ea8894d5580efdd82ba
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
par: Lugaresi A, et autres
Publié: (2013)

Disease-modifying therapies in relapsing&ndash;remitting multiple sclerosis
par: Fabricio Gonz&aacute;lez-Andrade, et autres
Publié: (2010)

Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
par: Julie A Murphy, et autres
Publié: (2010)

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes
par: Karl E. Carlström, et autres
Publié: (2019)

Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
par: Henrik Lund, et autres
Publié: (2013)

Secondary progressive and relapsing remitting multiple sclerosis leads to motor-related decreased anatomical connectivity.
par: Mark Lyksborg, et autres
Publié: (2014)

Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
par: Anne Waschbisch, et autres
Publié: (2011)

Synchronization within, and interactions between, the default mode and dorsal attention networks in relapsing-remitting multiple sclerosis
par: Huang M, et autres
Publié: (2018)

Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio
par: Ratthaporn Boonsuth, et autres
Publié: (2021)

A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis
par: Eoin F. McKinney, et autres
Publié: (2021)

Promising Effects of Vitex Agnus-Castus on Quality of Life and Sexual Function in Premenopausal Relapsing Remitting Multiple Sclerosis Patients
par: Sara Rahgooy, et autres
Publié: (2020)

Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review
par: Sylwia Pietrasik, et autres
Publié: (2021)

Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis
par: Tran JQ, et autres
Publié: (2016)

Functional cortical changes in relapsing-remitting multiple sclerosis at amplitude configuration: a resting-state fMRI study
par: Liu H, et autres
Publié: (2016)

Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls.
par: Andreas Keller, et autres
Publié: (2009)

Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis
par: Georgios Efthymiou, et autres
Publié: (2017)

Altered intra- and interregional synchronization in relapsing–remitting multiple sclerosis: a resting-state fMRI study
par: Wu L, et autres
Publié: (2016)

Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing&ndash;remitting multiple sclerosis?
par: Mezei Z, et autres
Publié: (2012)

Disconnection of the hippocampus and amygdala associated with lesion load in relapsing–remitting multiple sclerosis: a structural and functional connectivity study
par: Zhou F, et autres
Publié: (2015)

Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US survey
par: Gross HJ, et autres
Publié: (2017)

The Effect of Body Mass Index on Brain Volume and Cognitive Function in Relapsing–Remitting Multiple sclerosis: A CombiRx Secondary Analysis
par: Aliza Bitton Ben-Zacharia, et autres
Publié: (2021)

Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report
par: De Pasquale C, et autres
Publié: (2014)

CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS
par: I. P. Ivanova, et autres
Publié: (2021)

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study.
par: Francesco Patti, et autres
Publié: (2013)

Natalizumab for the treatment of relapsing multiple sclerosis
par: Richard A Rudick, et autres
Publié: (2008)

Remitting long-standing major depression in a multiple sclerosis patient with several concurrent conditions
par: Sachinvala ND, et autres
Publié: (2018)

A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis
par: Kerstin Hellwig, et autres
Publié: (2021)

Activities report of the working group on migration and trends in remitances
Publié: (2014)

Vitamin D and neurocognitive function
par: Schlögl M, et autres
Publié: (2014)

Neurocognitive endophenotypes: an update on the Field.
par: Jorge Mauricio Cuartas Arias, et autres
Publié: (2016)

Neurocognitive domains and neuropathological changes in experimental infection with Trypanosoma brucei brucei in Wistar rats
par: Olamide Elizabeth Adebiyi, et autres
Publié: (2021)

Pathways of the brain: The neurocognitive basis of language
par: Silva,Omer
Publié: (2000)

Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
par: Vellieux G, et autres
Publié: (2021)

Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
par: Dubey D, et autres
Publié: (2015)

Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis
par: Cohan S
Publié: (2016)

Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
par: Slobodan M Jankovic
Publié: (2010)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
par: Damiano Paolicelli, et autres
Publié: (2009)

Decision-making ability of professional managers based on neurocognitive
par: Liang Guo, et autres
Publié: (2019)

Neurocognitive development of novelty and error monitoring in children and adolescents
par: Kathleen Kang, et autres
Publié: (2021)

The Role of Perioperative Sleep Disturbance in Postoperative Neurocognitive Disorders
par: Wang X, et autres
Publié: (2021)